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ABSTRACT
In patients with heart valve disease, echocardiography
is the mainstay for diagnosis, assessment and serial
surveillance. However, other modalities, notably cardiac
MRI and CT, are used if echocardiographic imaging is
suboptimal but can also give complementary
information to improve assessment of the valve lesion
and cardiac compensation to aid the timing of surgery
and determine risk. This statement discusses the way
these imaging techniques are currently integrated to
improve care beyond what is possible with
echocardiography alone.
INTRODUCTION
Heart valve disease is common and a major
indication for imaging in all cardiac centres.
Imaging needs to assess: (1) valve morph-
ology to determine the aetiology and
suitability for invasive intervention; (2)
haemodynamic severity; (3) remodelling of
the left ventricle (LV) and right ventricle
(RV); (4) involvement of the aorta and (5)
the prediction of adverse cardiovascular
events. Echocardiography will continue as the
ﬁrst-line technique for diagnosis and is likely
to remain the mainstay for assessment and
serial surveillance in most cases. However,
other modalities, notably cardiac MRI (CMR)
and CT, are used if echocardiographic
imaging is suboptimal and can give comple-
mentary information, particularly to aid risk
assessment.
The purpose of this statement is to sum-
marise those multimodality approaches to
valve disease currently available and how
these might develop in the future. It is not
intended as a systematic review. The aim is to
encourage thinking beyond echocardiog-
raphy towards an integrated approach to
imaging in valve disease that uses each tech-
nique to its best advantage.
Aortic valve disease
Transthoracic echocardiography (TTE) is
used for assessing the aetiology and severity
of the valve disease and the remodelling
response of the LV. If echocardiographic
image quality is poor (table 1), CT or CMR
can image the valve (ﬁgure 1) while CMR
can measure velocities across the valve.1
Anatomical area on CT or CMR can be
useful and, although not the same as effect-
ive oriﬁce area, it is possible that a combin-
ation of anatomical area and calcium score
will give a reliable measure of the grade of
stenosis2 (ﬁgure 1).
In aortic stenosis, the echocardiographic
minimum data set is the peak transaortic vel-
ocity, the mean gradient and the effective
oriﬁce area,3 but these measures sometimes
give discordant results.2 CT can help resolve
this. First, the LV outﬂow tract may be oval
rather than circular4 and CT can assess the
size and shape of the LV outﬂow tract to
allow correction of the continuity equation.
This can also be carried out using three-
dimensional (3D) echocardiography pro-
vided that image quality is adequate.5
Second, CT can give a calcium score for the
valve which can differentiate severe from
more moderate stenosis6–8 with one sug-
gested cut-off of 2065 Agatston units (AU) in
males and 1275 AU in females.
The risk of events in aortic stenosis is
dependent on a number of factors including
the results of exercise testing. TTE suggests a
high risk of events if the Vmax has increased
by >0.3 m/s in a year with heavy calciﬁcation
as assessed subjectively,9 but quantiﬁcation of
calciﬁcation by CT is likely to be more accur-
ate.6 7 Fused positron emission tomography
(PET)/CT imaging with 18F-ﬂuoride could
assess both the burden of valve calciﬁcation
(CT calcium score) and its activity
(18F-ﬂuoride PET) and is of potential use in
reﬁning the prediction of aortic stenosis
progression.10 11
Estimation of the grade of aortic regurgita-
tion (AR) using multiple echocardiographic
modalities remains standard.12 However,
some situations, for example, a bicuspid
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valve with an eccentric jet, may be difﬁcult to assess and
CMR quantiﬁcation may provide useful complementary
information. In addition, there is evidence that CMR
identiﬁes patients at high risk of events better than does
TTE13 (ﬁgure 2). The quantiﬁcation of AR appears to
differ between echocardiography and CMR, with a
signiﬁcant overlap between grades, and a suggestion
of lower quantities by CMR than TTE (ﬁgure 2). This
may be due to differing techniques for each method,
and/or the potential for mild underestimation of AR by
CMR.
CT (ﬁgure 3) or CMR (ﬁgure 4) is already used in
clinical practice if the ascending aorta is not well
imaged on TTE or to check the aortic diameter when
approaching a surgical threshold. It may be better to use
CT when considering referral for aortic valve surgery
Table 1 Role of CT and CMR beyond those provided by echocardiography
Aortic stenosis
>CT Imaging of valve if echo window suboptimal
Imaging aorta if not seen clearly on echocardiography
LV outflow area to improve accuracy of continuity equation if grade uncertain
Aortic valve calcium (as a sign of severe aortic stenosis, eg, in low gradient low flow and as a marker of a
high risk of events on follow-up)
CT/PET to assess calcification and activity
Preintervention—coronary anatomy, detection of porcelain aorta, peripheral vessel anatomy, height of
coronary artery ostia above the valve
CMR Imaging of valve if echo window suboptimal
Imaging aorta if not seen clearly on echocardiography
LV mass if required for research, eg, to measure rate of regression after surgery
Future possibility of LV fibrosis as a sign suggesting early surgery
Aortic regurgitation
CT Imaging of valve if echo window suboptimal
Imaging aorta if not seen clearly on echocardiography
CMR Imaging of valve if echo window suboptimal
Imaging aorta if not seen clearly on echocardiography
Future possibility of surgery guided by LV volumes and early myocardial fibrosis
Mitral valve disease
MS
CT/CMR Imaging of valve if echo window suboptimal
MR
CT Refining imaging of subvalve apparatus before percutaneous mitral valve procedures
Predicting LV outflow tract obstruction after percutaneous mitral valve procedures
Quantifying mitral annulus calcification before mitral valve repair
CMR Imaging of valve if echo window suboptimal
Future possibility of surgery guided by LV volumes and evidence of early fibrosis
Right-sided valve disease
TR
CT No current indications
CMR RV volumes to guide surgery
Tricuspid annulus diameter to guide repair at the same time as left-sided surgery
PR
CT No current indications
CMR Better than echo for imaging the valve and detecting obstruction above or below the valve, and branch artery
stenoses
Quantification of pulmonary regurgitation
Quantification of serial RV volumes to guide surgery
Replacement heart valves
CT Imaging of leaflets or occluder to differentiate patient-prosthesis mismatch from pathological obstruction
Detection of pannus
CMR Quantification of regurgitation
Endocarditis
CT Detection of vegetation, eg, on heavily calcified valves
May detect aortic root abscess missed by echo
Coronary anatomy to avoid invasive angiography before surgery
CT/PET to detect endocarditis, eg, on replacement valves or electrical devices
CMR May detect root abscesses missed on echo
CMR, cardiac magnetic resonance imaging; MS, mitral stenosis; LV, left ventricle; PET, positron emission tomography; PR, pulmonary
regurgitation; TR, tricuspid regurgitation; RV, right ventricle.
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since this can also detect calcium in the ascending aorta
and identify porcelain aorta as an indication for a trans-
catheter procedure instead of conventional surgery. In
those at no more than moderate coronary risk (eg,
younger patients with a bicuspid aortic valve), CT can
produce an assessment of the aorta and coronary arter-
ies in one study. CT is also useful in the workup towards
intervention. For transcatheter aortic valve implantation,
it provides information additional to echo including the
degree of calciﬁcation of the leaﬂets, the distance to the
coronary arteries and the calibre, tortuosity and calciﬁc
burden of the peripheral vessels.14
Current thresholds for surgery in AR are based on
LV diameters on TTE, but these may be unreliable
since the LV becomes more spherical in severe AR
and a linear dimension may not be representative of
the whole LV. There is still little information on volu-
metric thresholds for surgery, but it is possible that LV
volumes by CMR will be better than those by TTE.
It is most likely that myocardial ﬁbrosis detected by
CMR15–17 will provide a powerful predictor of events in
aortic stenosis and regurgitation, but further work is
required before this can be recommended clinically.
CMR is far more accurate than TTE for quantifying LV
mass and is therefore useful in research studies to
document the regression of LV hypertrophy after
surgery,18 although it has not yet been shown to be a
prognostic marker.
Figure 1 Multimodality imaging
of aortic stenosis. (A) Contrast CT
imaging of the aortic valve can
provide detail regarding valve
morphology and the distribution of
calcification. (B) CT calcium
scoring allows reproducible
quantification of the calcific
burden, which acts as a marker of
disease severity. (C) Fused
positron emission tomography
and CT imaging with 18F-fluoride
provides an indication of ongoing
calcification activity in the valve.
CT has an important clinical role
in the workup of patients prior to
transcatheter aortic valve
implantation, providing accurate
dimensions of the annulus for
valve sizing (D) while cardiac MRI
can be used to planimeter the
aortic valve area (E) and to detect
replacement myocardial fibrosis,
red arrow (F).
Figure 3 Imaging the aorta using CT and cardiac MRI
(CMR). On the left is a reconstructed
three-dimensional-rendered CT scan of the heart with a
dilated ascending aorta and on the right is a steady-state free
precession (SSFP) image on CMR of a moderately dilated
ascending aorta.
Figure 2 Comparison of CMR and echocardiography in
aortic regurgitation. In 109 asymptomatic patients with
moderate or severe aortic regurgitation on echocardiography,
prognosis was better related to the regurgitant fraction on
CMR with a cut-point of 33%.The graph shows CMR
regurgitant fraction ≤ 33% in blue and >33% in red.
The regurgitation was either moderate or severe by
echocardiography in both of these two CMR groups.
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Mitral valve disease
TTE is the mainstay for assessing the aetiology, morph-
ology and grade of stenosis and regurgitation as well as
the adaptation of the right and left heart. A 3D echo,
particularly using transoesophageal echocardiography
(TOE), improves identiﬁcation of the minimum oriﬁce
for planimetry in mitral stenosis19 (ﬁgure 5) and may
also improve the assessment of valve anatomy and func-
tion of the valve in mitral regurgitation caused by mitral
prolapse19 (ﬁgure 6).
CMR is already used to assess mitral valve morphology
if the TTE window is suboptimal and quantiﬁcation can
be performed by CMR if the TTE is uncertain or pro-
duces discrepant results. In mitral regurgitation, thresh-
olds for surgery are based on a linear diameter on TTE,
but volumes are expected to be more reliable.20 This is a
potential role for CMR, although this is not a clinical
routine. It is possible that risk stratiﬁcation by CMR
assessment of the grade of MR and LV volumes may aid
the frequency of follow-up clinically and by echocardiog-
raphy and the need for functional tests.
CT can provide an assessment of mitral annular calciﬁca-
tion if this appears severe on TTE to help determine the
feasibility and safety of mitral repair or replacement. For
percutaneous mitral valve interventions, CT may also be
useful in further deﬁning mitral valve anatomy and the sub-
valve structures including false tendons and hypertrabecu-
lation. CT may be useful for predicting LV outﬂow tract
obstruction after percutaneous mitral valve implantation.
Tricuspid and pulmonary disease
TTE is used for initial diagnosis and will retain a ﬁrst-
line role into the future. However, CMR is used routinely
for the assessment of the RV in adult congenital
disease,21 and we believe it should be used more fre-
quently in severe tricuspid or pulmonary regurgitation
(table 1) where decisions for surgery rest on an accurate
assessment of RV volume, or a serial change in RV size
or function. It is also better for reﬁning the description
Figure 4 The aorta using cardiac MRI (CMR). (A) A contrast
MR angiogram showing critical coarctation and very dilated
thoracic collateral vessels. (B) A four-dimensional CMR flow
image showing very helical flow in the ascending aorta in a
patient with a bicuspid aortic valve.
Figure 5 A three-dimensional
(3D) echocardiogram showing
planimetry of a stenotic mitral
valve. The 3D image allows
alignment of the plane to ensure
that planimetry is performed at
the minimum orifice (courtesy Dr
Stam Kapetanakis).
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of the pulmonary valve, quantifying pulmonary regurgi-
tation looking for obstruction above and below the valve
and deﬁning branch pulmonary stenoses21 (ﬁgure 7).
CMR is particularly useful in larger adult patients in
whom assessment of the pulmonary valve with echocar-
diography may be difﬁcult.
Tricuspid valve repair may be recommended at the same
time as left-sided surgery depending on the grade of tricus-
pid regurgitation and the annulus diameter. The latter is
better assessed using 3D echocardiography than 2D and
also using CMR. CT is not usually helpful for right-sided
valve disease apart from excluding lung pathology contrib-
uting to elevated pulmonary artery pressures.
Replacement heart valves
TTE can usually make the initial diagnosis of valve
obstruction or abnormal regurgitation. However, TOE is
often needed to quantify paraprosthetic mitral regurgita-
tion to determine the cause of mitral obstruction.
CT is likely to have a key role in patients with unex-
pectedly high gradients, especially when immediate post-
implantation echocardiograms are not available
(table 1). In the early recovery period after surgery in
biological replacement valves, high gradients may be
caused by small thrombi at the base of the cusps and
these can be detected by CT22 23 but not by TTE or
TOE. Thereafter, the differentiation of patient-prosthesis
mismatch from primary failure in the aortic position
may be difﬁcult on TTE or even TOE since the cusps or
occluder may not be imaged fully. CT can then be used
for imaging the leaﬂet motion of bileaﬂet mechanical
valves, although ﬂuoroscopy may be still better for a
single tilting disc and caged-ball valves. Pannus is also
difﬁcult to detect by TTE and TOE, but there is growing
evidence that CT is useful24 (ﬁgure 8).
In mechanical replacement valves CMR can assess
forward ﬂow patterns and localise and quantify regurgi-
tant ﬂow. This is especially so for paravalvular leaks
(both in conventional and transcatheter replacement
valves), which can be challenging to assess with echocar-
diography. CMR is also useful for ventricular volumes
and function if TTE images are suboptimal.
Endocarditis
The complementary use of TTE and TOE has a high
sensitivity and speciﬁcity for vegetations and local
Figure 6 Three-dimensional
(3D) in mitral prolapse. (A) A 3D
image of the valve showing
prolapse of the middle scallop, P2
using the Carpentier
classification. (B) A
colour-contoured map with
prolapsing areas in red and
restricted areas in blue. The main
lesion is prolapse of the middle
portion of the anterior leaflet. (C)
A colour-contoured map in a
patient with functional mitral
regurgitation showing restriction
of both mitral leaflets (courtesy Dr
Stam Kapetanakis). A, anterior;
AL, anterolateral; Ao, aorta; P,
posterior; PM, posteromedial.
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complications.25 However, CT may be of value in detect-
ing vegetations on heavily calciﬁed valves26 27 and may
detect abscesses missed by TOE. CMR is not ideal for
detecting small vegetation due to their small size and
chaotic, highly mobile motion which presents problems
for the images acquired over several cardiac cycles. Both
CT and CMR are useful if aortic root pathology is not
well seen on TTE and if TOE is not feasible, or if there
is complex pathology (eg, false aneurysms or complex
abscesses). Coronary CT angiography can be considered
in place of invasive coronary angiography to avoid the
risk of dislodging vegetation.
In the future, combined PET-CT is likely to be useful
for diagnosing endocarditis in difﬁcult cases, for
example, infection of implantable electrical devices28
and replacement heart valves,29 although issues with a
myocardial uptake of this tracer will need to be resolved.
This indication is now included in the most recent
European Society of Cardiology guidelines on infective
endocarditis.30
Conclusion including future work
Multimodality imaging implies using each technique
where it has most to offer rather than simply repeating
full studies by each technique. Examples are surgery
based on a combination of severe aortic stenosis on TTE
and high CT calcium score, or trials of early surgery in
aortic and mitral regurgitation based on CMR assess-
ment of regurgitant fraction and LV volumes. This
approach has obvious advantages but has not been
tested clinically and is largely unresearched. This state-
ment is intended to draw attention to the exciting possi-
bilities and to act as a call for the research community
to plan collaborative projects.
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